Who makes januvia?

Merck & Co. manufactures Januvia [1]. Januvia is a prescription medication used to treat type 2 diabetes [2]. It belongs to a class of drugs called DPP-4 inhibitors [2].

What is the active ingredient in Januvia?

The active ingredient in Januvia is sitagliptin [3]. Sitagliptin works by increasing levels of incretin hormones, which help regulate blood sugar [2].

When did Januvia receive FDA approval?

The U.S. Food and Drug Administration (FDA) approved Januvia in October 2006 [4].

Are there other drugs like Januvia?

Yes, other DPP-4 inhibitors are available, including Tradjenta (linagliptin), Onglyza (saxagliptin), and Nesina (alogliptin) [5]. These medications are also used to manage type 2 diabetes.

When does Januvia's patent expire?

Information regarding the specific patent expiry dates for Januvia can be found on DrugPatentWatch.com [6]. Patent protection can be complex and may involve multiple patents covering different aspects of the drug [6].